The US Blood Plasma Derivatives Market has experienced significant growth in recent years, driven by increasing domestic demand for immunoglobulin therapies, rising hemophilia prophylaxis adoption, and growing recognition of plasma-derived products as essential biologics with limited manufacturing alternatives. The United States dominates global plasma collection and fractionation, supplying...